Literature DB >> 25901654

Molecular dyes used for surgical specimen margin orientation allow for intraoperative optical assessment during breast conserving surgery.

David M McClatchy1, Venkataramanan Krishnaswamy1, Stephen C Kanick1, Jonathan T Elliott1, Wendy A Wells2, Richard J Barth3, Keith D Paulsen4, Brian W Pogue5.   

Abstract

A variety of optical techniques utilizing near-infrared (NIR) light are being proposed for intraoperative breast tumor margin assessment. However, immediately following a lumpectomy excision, the margins are inked, which preserves the orientation of the specimen but prevents optical interrogation of the tissue margins. Here, a workflow is proposed that allows for both NIR optical assessment following full specimen marking using molecular dyes which have negligible absorption and scattering in the NIR. The effect of standard surgical inks in contrast to molecular dyes for an NIR signal is shown. Further, the proposed workflow is demonstrated with full specimen intraoperative imaging on all margins directly after the lumpectomy has been excised and completely marked. This work is an important step in the path to clinical feasibility of intraoperative breast tumor margin assessment using NIR optical methods without having to compromise on the current clinical practice of inking resected specimens for margin orientation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25901654      PMCID: PMC4406078          DOI: 10.1117/1.JBO.20.4.040504

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  14 in total

1.  Low-coherent backscattering spectroscopy for tissue characterization.

Authors:  Young L Kim; Yang Liu; Ramesh K Wali; Hemant K Roy; Vadim Backman
Journal:  Appl Opt       Date:  2005-01-20       Impact factor: 1.980

2.  Method of obtaining optical sectioning by using structured light in a conventional microscope.

Authors:  M A Neil; R Juskaitis; T Wilson
Journal:  Opt Lett       Date:  1997-12-15       Impact factor: 3.776

3.  Multimodal optical imaging for detecting breast cancer.

Authors:  Rakesh Patel; Ashraf Khan; Dennis Wirth; Michal Kamionek; Dina Kandil; Robert Quinlan; Anna N Yaroslavsky
Journal:  J Biomed Opt       Date:  2012-06       Impact factor: 3.170

4.  Optical assessment of tumor resection margins in the breast.

Authors:  J Quincy Brown; Torre M Bydlon; Lisa M Richards; Bing Yu; Stephanie A Kennedy; Joseph Geradts; Lee G Wilke; Marlee Junker; Jennifer Gallagher; William Barry; Nimmi Ramanujam
Journal:  IEEE J Sel Top Quantum Electron       Date:  2010-03-01       Impact factor: 4.544

5.  A device for real-time, intraoperative margin assessment in breast-conservation surgery.

Authors:  Tami Karni; Itzhak Pappo; Judith Sandbank; Oleg Lavon; Varda Kent; Rona Spector; Sara Morgenstern; Shlomo Lelcuk
Journal:  Am J Surg       Date:  2007-10       Impact factor: 2.565

6.  Scatter spectroscopic imaging distinguishes between breast pathologies in tissues relevant to surgical margin assessment.

Authors:  Ashley M Laughney; Venkataramanan Krishnaswamy; Elizabeth J Rizzo; Mary C Schwab; Richard J Barth; Brian W Pogue; Keith D Paulsen; Wendy A Wells
Journal:  Clin Cancer Res       Date:  2012-08-20       Impact factor: 12.531

7.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

Authors:  Umberto Veronesi; Natale Cascinelli; Luigi Mariani; Marco Greco; Roberto Saccozzi; Alberto Luini; Marisel Aguilar; Ettore Marubini
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

8.  Quantitative imaging of scattering changes associated with epithelial proliferation, necrosis, and fibrosis in tumors using microsampling reflectance spectroscopy.

Authors:  Venkataramanan Krishnaswamy; P Jack Hoopes; Kimberley S Samkoe; Julia A O'Hara; Tayyaba Hasan; Brian W Pogue
Journal:  J Biomed Opt       Date:  2009 Jan-Feb       Impact factor: 3.170

Review 9.  Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.

Authors:  Rick G Pleijhuis; Maurits Graafland; Jakob de Vries; Joost Bart; Johannes S de Jong; Gooitzen M van Dam
Journal:  Ann Surg Oncol       Date:  2009-07-17       Impact factor: 5.344

10.  Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging.

Authors:  Ashley M Laughney; Venkataramanan Krishnaswamy; Elizabeth J Rizzo; Mary C Schwab; Richard J Barth; David J Cuccia; Bruce J Tromberg; Keith D Paulsen; Brian W Pogue; Wendy A Wells
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

View more
  5 in total

1.  Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy.

Authors:  Yu Winston Wang; Nicholas P Reder; Soyoung Kang; Adam K Glaser; Qian Yang; Matthew A Wall; Sara H Javid; Suzanne M Dintzis; Jonathan T C Liu
Journal:  Cancer Res       Date:  2017-06-14       Impact factor: 12.701

Review 2.  Optical and x-ray technology synergies enabling diagnostic and therapeutic applications in medicine.

Authors:  Brian W Pogue; Brian C Wilson
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

Review 3.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

Review 4.  Review of methods for intraoperative margin detection for breast conserving surgery.

Authors:  Benjamin W Maloney; David M McClatchy; Brian W Pogue; Keith D Paulsen; Wendy A Wells; Richard J Barth
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

5.  Structured light imaging for breast-conserving surgery, part I: optical scatter and color analysis.

Authors:  Benjamin W Maloney; Samuel S Streeter; David M McClatchy; Brian W Pogue; Elizabeth J Rizzo; Wendy A Wells; Keith D Paulsen
Journal:  J Biomed Opt       Date:  2019-09       Impact factor: 3.170

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.